Error: Could not add to watchlist. X

NPS Pharmaceuticals Inc

+ Watchlist
NPSP:US
Acquired
NPSP:US was acquired by SHP:LN
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.08
Market Cap (USD)
-
Shares Outstanding (m)
108.581
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.
ADDRESS
550 Hills Drive
3rd Floor
Bedminster, NJ 07921
United States
PHONE
1-908-450-5300
  • Paul Firuta
    President:US Commercial Ops
  • Roger J Garceau
    Exec VP/Chief Medical Officer
  • Robin Friedman
    Senior VP:Human Resources
  • Susan E Graf
    VP:Corporate Dev & Strategy
  • Christine Mikail
    Senior VP:Legal Affairs/Gen Cnsl
Show More